Home About us MoEF Contact us Sitemap Tamil Website  
About Envis
Whats New
Microorganisms
Research on Microbes
Database
Bibliography
Publications
Library
E-Resources
Microbiology Experts
Events
Online Submission
Access Statistics

Site Visitors

blog tracking


 
Journal of Acquired Immune Deficiency Syndromes
Vol. 68 (2), 2015, Pages: 241–244

Illustration of a Measure to Combine Viral Suppression and Viral Rebound in Studies of HIV Therapy

Edwards, Jessie K., Cole, Stephen R., Adimora, Adaora Fine, Jason Martin, Jeff, Eron, Joseph



Abstract

Viral load is an important tool for assessing antiretroviral treatment efficacy. However, the most common viral load end point, virologic failure, may be flawed. We illustrate an alternative end point that estimates the average time patients spent suppressed before rebound in the AIDS Clinical Trials Group A5095 trial. Patients averaged 644 days suppressed in the 3-drug arm and 686 days suppressed in the 4-drug arm, for a difference of 42 days in favor of the 4-drug regimen (95% confidence interval: −11 to 96). These results agree with results using virologic failure as the end point but better emphasize the separate suppression and rebound processes.

 


 
Copyright © 2005 ENVIS Centre ! All rights reserved
This site is optimized for 1024 x 768 screen resolution